Financial Performance - Net sales for Q2 2024 were 586.4million,a11.8524.6 million in Q2 2023[58] - The company reported a net loss of 25.8million,or1.55 per diluted share, compared to a net income of 29.7million,or1.75 per diluted share in the same quarter last year[58] - Adjusted EBITDA for Q2 2024 was 35.3million,down50.771.5 million in Q2 2023[58] - For the first half of 2024, net sales increased by 3% to 1.1billioncomparedto1 billion in the first half of 2023[58] - The company recorded a net loss of 8.6millionforthefirsthalfof2024,comparedtoanetincomeof53.5 million in the same period last year[58] - Adjusted EBITDA for the first half of 2024 was 96.8million,adecreaseof29.4137.2 million in the first half of 2023[58] Segment Performance - Paperboard segment net sales increased by 26.1% to 331.5millioninQ22024comparedto263.0 million in Q2 2023[66] - Paperboard shipments increased by 46.4% to 272,585 short tons in Q2 2024 compared to 186,160 short tons in Q2 2023[66] - Operating income for the paperboard segment was a loss of 12.2millioninQ22024,adecreaseof129.142.0 million in Q2 2023[66] - The company experienced a significant decrease in sales prices in the Pulp and Paperboard segment due to previously announced price decreases and changes in product mix[66] - Retail tissue net sales for the quarter ended June 30, 2024, were 252.0million,adecreaseof0.3252.8 million in the prior year[68] - Operating income for the quarter increased by 9.7% to 27.4millionfrom25.0 million in the same period last year[68] - Adjusted EBITDA for the quarter was 41.4million,reflectinga4.339.7 million year-over-year[68] Cash Flow and Investments - Net cash flows provided by operating activities for the six months ended June 30, 2024, were 80.3million,comparedtoacashoutflowof36.9 million in the same period of 2023[74] - Net cash flows used in investing activities for the six months ended June 30, 2024, were 744.8million,including708.2 million for the acquisition of a paperboard manufacturing facility[75] - Net cash provided by financing activities for the six months ended June 30, 2024, was 662.1million,primarilyfromtheissuanceoflong−termdebt[76]CorporateExpensesandOutlook−Corporateexpensesforthequarterwere17.7 million, down from 20.1millioninthesameperiodlastyear[70]−RetailsalesvolumesintheConsumerProductssegmentincreasedduetohigherdemandforprivatelabelproducts[69]−Thecompanyexpectscapitalexpenditurestobeapproximately120 million to 140millionduring2024[75]DebtandFinancing−TheTermCreditAgreementincludesatermrevolverloancommitmentof270 million, with 150millionborrowedasofOctober27,2023[77]−TheCompanyhasa150 million borrowing under the Term Revolver Facility with an all-in interest rate of 9.13%[78] - The Term Loan Facilities require mandatory prepayments of 50% of quarterly excess cash flows, less any voluntary prepayments[78] - The Company must maintain a maximum consolidated leverage ratio of 4.50 to 1.00 until the first fiscal quarter ending at least 15 months after May 1, 2024[78] - Under the ABL Credit Agreement, the Company has a 375millionrevolvingloancommitment,maturingonNovember7,2027[79]−TheABLCreditAgreementrequiresaconsolidatedfixedchargecoverageratioofnotlessthan1.10xto1.00xduringaneventofdefault[79]−TheCompanyiscurrentlyincompliancewiththecovenantsassociatedwithboththeTermCreditAgreementandtheABLCreditAgreementasofJune30,2024[79]−InterestratesforloansundertheTermLoanFacilitiesmayvarybetween1.75100 million, subject to conditions[78] - The Company is required to maintain a minimum current ratio of not less than 1.25 to 1.00 under the Term Credit Agreement[78] Market Risk - There have been no significant developments regarding the Company's exposure to market risk for the quarter ended June 30, 2024[81]